ArticleJournal of central nervous system disease2026
The Prevalence and Characteristics of Obstructive Sleep Apnea Among Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Article in Journal of central nervous system disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with multiple sclerosis (MS) report high prevalence of sleep fragmentation and poor sleep quality. However, the relationship between sleep and MS is poorly understood. Objectives: To identify the prevalence of obstructive sleep apnea (OSA) among patients with MS, assess the difference between patients with MS and healthy controls in sleep metrics detected by polysomnography, and evaluate the impact of OSA metrics on disability indices. Design: Systematic review and meta-analysis. Methods: On September 29, 2025, we searched PubMed, Embase, Scopus, CINAHL and CENTRAL. The inclusion criteria were observational studies that included patients with MS who underwent polysomnography and reported the prevalence of OSA, the difference in polysomnography data such as total sleep time, sleep efficiency, and apnea hypopnea index (AHI) between patients with MS and healthy controls or the correlation between the aforementioned polysomnography variables and MS disability indicated by expanded disability status scale (EDSS) or symbol digit modality test (SDMT). Weighted mean difference (WMD) and rho (r) correlation coefficient and their associated 95% confidence intervals (95%CI) were used as the effect measures in the analysis. Results: A total of 3,264 patients with MS and 679 healthy controls from 40 studies were included in the analysis. The prevalence of OSA among patients with MS was 44% (95%CI: 33%-56%). Patients with MS had lower total sleep time (WMD=-37.70; 95%CI: -62.27- -13.12) and sleep efficiency (WMD=-6.38; 95%CI: -9.71- -3.06) and higher AHI (WMD=1.76; 95%CI: 0.20-3.32) compared to healthy controls. Sleep efficiency (r=-0.16; 95%CI: -0.02- -0.29) and AHI (r=0.41; 95%CI: 0.26-0.54) were correlated with EDSS. Conclusions: It is fundamental to screen patients with MS for OSA and offer management options such as continuous positive airway pressure (CPAP) when appropriate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.